David Lodge

David Lodge publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where David Lodge sits on this spectrum.

David Lodge D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where David Lodge sits on this spectrum.

Research.com Recognitions

• 2016 - Fellow of the Royal Society, United Kingdom
• Fellow of The Academy of Medical Sciences, United Kingdom
• Fellow of The Academy of Medical Sciences, United Kingdom

Best Publications

• The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate

  Unknown

  1406
  Citations

• Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

  Unknown

  1226
  Citations

• Evidence for involvement ofN-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat

  Unknown

  666
  Citations

• Neuropharmacology of AMPA and kainate receptors

  David Bleakman;David Lodge

  497
  Citations

• A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission

  Vernon R. J. Clarke;Barbara A. Ballyk;Ken H. Hoo;Allan Mandelzys

  486
  Citations

• An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?

  Unknown

  446
  Citations

• Kainate receptors are involved in synaptic plasticity

  Zuner A. Bortolotto;Vernon R. J. Clarke;Caroline M. Delany;Michael C. Parry

  412
  Citations

• New class of glutamate agonist structurally related to ibotenic acid

  P. Krogsgaard-Larsen;T. Honoré;J. J. Hansen;D. R. Curtis

  405
  Citations

• Classification and nomenclature of phencyclidine and sigma receptor sites

  Rémi Quirion;Robert Chicheportiche;Patricia C. Contreras;Kenneth M. Johnson

  385
  Citations

• A new class of GABA agonist.

  P. Krogsgaard-Larsen;G. A. R. Johnston;D. Lodge;D. R. Curtis

  383
  Citations

• Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus

  Thomas E. Bartlett;Neil J. Bannister;Valerie J. Collett;Sheila L. Dargan

  375
  Citations

• Kainate receptors: pharmacology, function and therapeutic potential.

  David E Jane;David Lodge;Graham L Collingridge

  327
  Citations

• Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.

  David Bleakman;Barbara A Ballyk;Darryle D Schoepp;Andrew J Palmer

  279
  Citations

• Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices

  Stephen M. Fitzjohn;Andy J. Irving;Mary J. Palmer;Jenni Harvey

  262
  Citations

• The antagonism of amino acid-induced excitation of spinal neurones in the cat

  Unknown

  258
  Citations

• A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP.

  Sari E Lauri;Zuner A Bortolotto;David Bleakman;Paul L Ornstein

  255
  Citations

• Dihydromuscimol, thiomuscimol and related heterocyclic compounds as GABA analogues.

  P. Krogsgaard‐Larsen;H. Hjeds;D. R. Curtis;D. Lodge

  255
  Citations

• DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists

  Stephen M Fitzjohn;Ann E Kingston;David Lodge;Graham L Collingridge

  243
  Citations

• A Role for Ca2+ Stores in Kainate Receptor-Dependent Synaptic Facilitation and LTP at Mossy Fiber Synapses in the Hippocampus

  Sari E Lauri;Zuner A Bortolotto;Robert Nistico;David Bleakman

  241
  Citations

• The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model

  Unknown

  192
  Citations